Needle-free Delivery

Berna and Iomai announce collaboration for patch delivery of vaccines

Published in Vaccine Weekly, June 26th, 2002

Berna Biotech, Ltd., (BBIN) and Iomai Corp., a private biopharmaceutical company, announced a collaboration for the development of vaccines for administration using a skin patch.

The collaboration will pool Berna's expertise in the development of vaccines and novel adjuvants with Iomai's expertise in skin delivery using its proprietary patch technology. Needle-free delivery has become a global priority because of the risk of needle-borne diseases associated with reuse and improper disposal of needles. Delivery of vaccines across the skin using a patch not only addresses this issue, but may elicit a stronger immune response through delivery to the skin, an area rich in...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2002-06-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry